ResearchWho?

조병철

교수

연세대학교(신촌) 의과대학 의학과

논문[255]

#255. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

2022.06 · LANCET ONCOLOGY

(DOI) https://doi.org/10.1016/S1470-2045(22)00226-1

#254. Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience

2022.05 · CANCER IMMUNOLOGY IMMUNOTHERAPY

(DOI) https://doi.org/10.1007/s00262-021-03052-w

특허[3]

#3. 상승적 치료 효과를 갖는 비소세포폐암의 예방 또는 치료용 조성물

대한민국

#2. 암 전이 진단용 키트 및 암 전이 진단을 위한 정보제공방법

대한민국